seven of these Ozempic is still the GLP-1 king, but Lilly is rapidly gaining market share, with its Q2 2024 sales reaching $3.01 billion compared to Novo Nordisks $5.38 billion
This ensures that the compounded semaglutide you receive is a high-quality product designed to meet clinical standards
If you are struggling with constipation AND reflux, heartburn, indigestion, nausea, etc., check out our Relux + Motility kit
If you are ready to see whether a personalized program is a fit, you can take the free assessment quiz
Beginning at the lowest dose (typically 0.25 mg weekly) gives your digestive system time to adapt before advancing to higher concentrations
Microbiome and metabolic disease: revisiting the bacterial phylum Bacteroidetes [J]